tirzepatide breastfeeding data - Drugs and Lactation Database (LactMed®) Breastfeeding shouldn't automatically exclude you
Description
55 Over 26 weeks, HbA1c improved by 1.6% to 2.4% with tirzepatide 5 to 15 mg compared to 1.1% reduction with dulaglutide and 0.1% HbA1c increase with placebo
Eating smaller meals, drinking more water, and avoiding fizzy drinks can help
Moderate exposure: 4 to 24 hours at room temperature A full night on the counter
By the 8-12 week mark, the majority of users who experienced early body aches report significant improvement or complete resolution
RR, risk ratio
